Latest Star Scientific Inc. Stories
GLEN ALLEN, Va., Jan. 25, 2011 /PRNewswire/ -- Star Scientific, Inc. (Nasdaq: CIGX) today announced that the company's patent counsel has received a decision from the U.S. Patent and Trademark Office (PTO) granting Star's request to reopen the reexaminations of Star's '649 and '401 patents. The PTO agreed with Star's counsel that applicable PTO procedures had been satisfied: the decision reverses a previous May 2010 decision of intent to cancel the involved claims on the ground that Star...
Company Must Meet Strict Standards of Scientific Proof and Benefit to Public Health WASHINGTON, Jan. 4, 2011 /PRNewswire-USNewswire/ -- The following is a statement of Matthew L. Myers, President, Campaign for Tobacco-Free Kids: (Logo: http://photos.prnewswire.com/prnh/20080918/CFTFKLOGO) Star Scientific Inc.'s plan to submit a new, moist-snuff product for evaluation by the Food and Drug Administration as a "modified risk" tobacco product shows the vital importance of the new law giving...
Tobacco maker Star Scientific Inc. said today that it has developed a moist smokeless tobacco with lower levels of cancer-causing chemicals than other tobacco products. The company said Tuesday that it plans to so ask the Food and Drug Administration (FDA) for approval to sell the new item as safer than any competing product. Star Scientific hopes that its products will be the first the FDA allows to be marketed as less harmful than other forms of tobacco. The company said that the...
GLEN ALLEN, Va., Nov. 10, 2010 /PRNewswire-FirstCall/ -- Star Scientific, Inc. (Nasdaq: CIGX) filed the company's third-quarter financial report yesterday with the Securities & Exchange Commission. The company reported $695 thousand in net sales for the nine months ended September 30, 2010 compared with $618 thousand for the same period in 2009. Net sales for the third quarter totaled $211 thousand compared with $232 thousand for third-quarter 2009. The decrease in third-quarter 2010...
GLEN ALLEN, Va., Nov. 8, 2010 /PRNewswire/ -- Star Scientific, Inc. (Nasdaq: CIGX) announced that on November 5, 2010, certain members of management, directors and existing long-term shareholders purchased $14,000,000 of restricted securities from the Company to provide additional working capital and to assist in bringing to market Star's new products. The transaction was a private placement with accredited investors and involved the purchase and sale of 7,597,400 shares of the Company's...
GLEN ALLEN, Va., Oct. 7 /PRNewswire-FirstCall/ -- Star Scientific, Inc. (Nasdaq: CIGX) has issued the following comment by Paul L. Perito, Rock Creek Pharmaceuticals' Chairman and CEO: (Logo: http://www.newscom.com/cgi-bin/prnh/20090317/STARSCIENTIFICLOGO ) (Logo: http://photos.prnewswire.com/prnh/20090317/STARSCIENTIFICLOGO ) "We are gratified that the Roskamp Institute, a highly credentialed scientific foundation, has made a significant medical discovery that we believe holds the...
GLEN ALLEN, Va., Oct. 4 /PRNewswire/ -- Star Scientific, Inc. (Nasdaq: CIGX) today announced that the company's patent counsel has received a letter from the US Patent & Trademark Office (PTO) that vacates the PTO's May, 2010 Notice of Intent to Terminate the reexamination of the Star Scientific's " '649" and " '401" patents. The letter requests that the patent owner demonstrate that the present record is complete or, in the alternative, file a routine petition to reopen the...
GLEN ALLEN, Va., Aug. 5 /PRNewswire/ -- Star Scientific, Inc. (Nasdaq: CIGX) today announced that CigRx(TM), a dietary supplement developed by the company's Rock Creek Pharmaceuticals subsidiary, has been launched in the greater Richmond, Virginia area. CigRx(TM), a mint-flavored lozenge that dissolves in the mouth and is swallowed, contains neither nicotine nor tobacco and was developed for adult dependent smokers. CigRx(TM) temporarily reduces the urge to smoke using a unique combination...
GLEN ALLEN, Va., June 21 /PRNewswire-FirstCall/ -- Star Scientific, Inc. (Nasdaq: CIGX) announced that on Friday, June 18 the company filed an application with the Food & Drug Administration for approval to market Stonewall-BDL(TM) as a "modified risk tobacco product" under the Family Smoking Prevention and Tobacco Control Act of 2009. This is Star's second such application to the Tobacco Products Center of the FDA, which has been established to oversee all aspects of tobacco...
GLEN ALLEN, Va., June 10 /PRNewswire-FirstCall/ -- Star Scientific, Inc. (Nasdaq: CIGX) issued the following statement today from Paul L. Perito, the company's Chairman and President: (Logo: http://photos.prnewswire.com/prnh/20090317/STARSCIENTIFICLOGO ) Curtis Wright, MD, MPH, Senior Vice President and Ryan Lanier, Ph.D., of Rock Creek Pharmaceuticals, made a presentation on tobacco toxins on Tuesday June 8 to the FDA Tobacco Products Scientific Advisory Subcommittee on Tobacco Product...
